Loading...
Thumbnail Image
Publication

Bcl2:Beclin 1 complex: multiple mechanisms regulating autophagy/apoptosis toggle switch

Marquez, Rebecca T.
Xu, Liang
Citations
Altmetric:
Abstract
Cancer cells have developed novel mechanisms for evading chemotherapy-induced apoptosis and autophagy-associated cell death pathways. Upon the discovery that chemotherapeutics could target these cell death pathways in a manner that was not mutually exclusive, new discoveries about the interrelationship between these two pathways are emerging. Key proteins originally thought to be “autophagy-related proteins” are now found to be involved in either inducing or inhibiting apoptosis. Similarly, apoptosis inhibiting proteins can also block autophagy-associated cell death. One example is the complex formed by the autophagy protein, Beclin 1, and anti-apoptotic protein Bcl-2, which leads to inhibition of autophagy-associated cell death. Researchers have been investigating additional mechanisms that form/disrupt this complex in order to better design chemotherapeutics. This review will highlight the role Bcl-2 and Beclin 1 play in cancer development and drug resistance, as well as the role the Bcl-2:Beclin 1 complex in the switch between autophagy and apoptosis.
Description
This is the published version, also available here: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3304572/.
Date
2012-02-28
Journal Title
Journal ISSN
Volume Title
Publisher
e-Century Publishing
Research Projects
Organizational Units
Journal Issue
Keywords
Apoptosis, autophagy, Bcl-2, Beclin 1, Gossypol, BH3 mimetics
Citation
Marquez, Rebecca T. & Xu, Liang. "Bcl2:Beclin 1 complex: multiple mechanisms regulating autophagy/apoptosis toggle switch." (2011) Am J Cancer Res. 2012; 2(2): 214–221.
DOI
Embedded videos